Liver ischemia: Apoptosis as a central mechanism of injury

Journal of Investigative Surgery

Volumn 16, Issue 3, 2003, Pages 149-159

  Rüdiger, Hannes A ^a   Graf, Rolf ^a   Clavien, Pierre Alain ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Apoptosis; Caspase; Ischemia; Liver injury; Necrosis

Indexed keywords

APOPTOSIS INHIBITOR; CASPASE; CASPASE INHIBITOR; LIPOSOME; PRESERVATION SOLUTION; PROTEIN BCL 2;

APOPTOSIS; CELL DEATH; CELL FUNCTION; DRUG EFFICACY; ENZYME INHIBITION; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; IMMUNOLOGICAL TOLERANCE; KUPFFER CELL; LIVER ISCHEMIA; LIVER PRESERVATION; LIVER SURGERY; LIVER TRANSPLANTATION; MORBIDITY; MORTALITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SURVIVAL; TREATMENT OUTCOME;

EID: 0042991493     PISSN: 08941939     EISSN: None     Source Type: Journal    
DOI: 10.1080/08941930390205764     Document Type: Review

References (97)

1. Clavien PA, Harvey PR, Strasberg SM. Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation. 1992;53(5):957-978.
2. Schnitzler M, Woodward R, Brennan D, et al. The economic impact of preservation time in cadaveric liver transplantation. Am J Transpl. 2001;1:360-365.
3. Gao W, Bentley RC, Madden JF, Clavien PA. Apoptosis of sinusoidal endothelial cells is a critical mechanism of prevention injury in rat liver transplantation. Hepatology. 1998;27:1652-1660.
4. Natori S, Selzner M, Valentino K, et al. Apoptosis of sinusoidal endothelial cells occurs during liver preservation injury by a caspase-dependent mechanism. Transplantation. 1999;68:89-96.
5. Kohli V, Selzner M, Madden J, et al. Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia-reperfusion injury in the rat liver. Translantation. 1999;67(8):1099-1105.
6. Cursio R, Guggenheim J, Ricci J, et al. A caspase inhibitor fully protects rats against lethal normothermic liver ischemia by inhibition of liver apoptosis. FASEB J. 1999;113:253-261.
7. Clavien P, Rudiger H, Selzner M. Mechanisms of hepatocyte death after ischemia: Apoptosis versus necrosis. Hepatology. 2001;33(6):1555-1556.
8. Jaeschke H, Gujra J, Bucci T, Farhood A. Mechanisms of cell death during warm hepatic ischemia-reperfsuion in rats: Apoptosis and necrosis? [Letter]. Hepatology. 2001;33(6):1556-1557.
9. Clavien PA, Yadav S, Sindram D, Bentley RC. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg. 2000;232:155-162.
10. Kerr JF, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26(4):239-257.
11. Lemasters J. Necrapoptosis and the mitochondrial permeability transition: Shared pathways to necrosis and apoptosis. Am J Physiol. 1999;276(1):G1-G6.
12. Selzner M, Rudiger H, Sindram D, et al. Mechanisms of ischemic injury are different in the steatotic and normal rat liver. Hepatology. 2000;32:1280-1288.
13. Pringle J. Notes on the arrest of hepatic hemorrhage due to trauma. Ann Surg. 1908;48:541-549.
14. Belghiti J, Noun R, Malafosse R, et al. Continuous versus intermittent portal triad clamping for liver resection: A controlled study. Ann Surg. 1999;229(3):369-375.
15. Kohli V, Madden JF, Bentley RC, Clavien PA. Calpain mediates ischemic injury of the liver through modulation of apoptosis and necrosis. Gastroenterology. 1999;116(1):168-178.
16. Chien C, Cheng C, Lai W, et al. Repetitive ischemia/reperfusion potentiates hepatocellular death by apoptosis. Transpl Proc. 1999;13:2926-2927.
17. Cursio R, Gugenheim J, Ricci J, et al. Caspase inhibition protects from liver injury following ischemia and reperfusion in rats. Transpl Int. 2000;13(Suppl 1):S568-S572.
18. Selzner M, Rudiger H, Malekkiani N, et al. Bcl-2 overexpression in transgenic mice protects against ischemia & reperfusion injury of the liver. J Hepatol. 2002;36:218-225.
19. Rudiger H, Kang K, Sindram D, et al. Comparison of ischemic preconditioning, intermittent and continuous inflow occlusion in the murine liver. Ann Surg. 2002;235:400-407.
20. Rudiger H, Clavien P-A. Tumor necrosis factor-alpha, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver. Gastroenterology. 2002;122:202-210.
21. Sindram D, Kohli V, Madden J, Clavien P-A. Calpain inhibition prevents sinusoidal endothelial cell apoptosis in the cold ischemic rat liver. Transplantation. 1999;68:136-140.
22. Sindram D, Porte RJ, Hoffman MR, et al. Platelets induce sinusoidal endothelial cell apoptosis upon reperfusion of the cold ischemic rat liver. Gastroenterology. 2000;118(1):183-191.
23. Gollacker B, Sedivy R, Rockenschaub S, et al. Increased apoptosis of hepatocytes in vascular occlusion after orthotopic liver transplantation. Transpl Int. 2000;13:49-53.
24. Sindram D, Prote R, Hoffmann M, et al. Synergism between platelets and leukocytes in inducing endothelial cell apoptosis in the cold ischemic rat liver: A Kupffer-mediated injury. FASEB J. 2001;15:1230-1232.
25. Sindram D, Rudiger H, Upadhya A, et al. Ischemic preconditioning protects against cold ischemic injury through an oxidative stress dependent mechanism. J Hepatol. 2002;36:78-84.
26. Yokoyama I, Hayashi S, Kobayashi T, et al. Hepatocyte apoptosis and cytosolic calcium dynamics in ischemic injury. Transplant Proc. 1997;29(8):3514.
27. Borghi-Scoazec G, Scoazec JY, Durand F, et al. Apoptosis after ischemia-reperfusion in human liver allografts. Liver Transplant Surg. 1997;3(4):407-415.
28. Sasaki H, Matsuno T, Nakagawa K, Tanaka N. Induction of apoptosis during the early phase of reperfusion after rat liver ischemia. Acta Med Okayama. 1997;51(6):305-312.
29. Tsuchiya T, Abe T, Saito T, et al. Induction of immediate early genes and apoptosis after ischemia/reperfusion in fatty liver rats. Transplant Proc. 1998;30(7):2919-2922.
30. Rudiger HA, Clavien PA. A cytotoxic drug against reperfusion injury? Hepatology. 2000;31(2):533-535.
31. Li P, Nijhawan D, Budihardjo I, et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 1997;91(4):479-489.
32. Li H, Zhu H, Xu CJ, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 1998;94(4):491-501.
33. Scaffidi C, Fulda S, Srinivasan A, et al. Two CD95 (APO1/Fas) signaling pathways. EMBO J. 1998;17(6):1675-1687.
34. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med. 1997;3:614-620.
35. White E. Life, death, and the pursuit of apoptosis. Genes Dev. 1996;10:1-15.
36. Shimuzu S, Eguchi Y, Kosaka H, et al. Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature. 1995;374:811-813.
37. Bilbao G, Contreras J, Eckhoff D, et al. Reduction of ischemia-reperfusion injury of the liver by in vivo adenovirus-mediated gene transfer of the antiapoptotic Bcl-2 gene. Ann Surg. 1999;230:185-192.
38. Yamabe K, Shimiyu S, Kamiike W, et al. Prevention of hypoxic liver cell noectosis by in vivo human bcl-2 gene transfection. Biochem Biophys Res Commun. 1998;243:217-223.
39. Colletti L, Remick D, Burtch G, et al. Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest. 1990;85:1936-1943.
40. Colletti L, Kunkel S, Walz A, et al. The role of cytokine networks in the local liver injury following heptic ischemia/reperfusion in the rat. Hepatology. 1996;23:506-514.
41. Wanner G, Muller P, Ertel W, et al. Differential effect of anti-TNF-alpha antibody on proinflammatory cytokine release by Kupffer cells following liver ischemia and reperfusion. Shock. 1999;11(6):391-395.
42. Decker K. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem. 1990;192:245-261.
43. Clemens M, Bauer M, Pannen B, et al. Remodeling of hepatic microvascular responsiveness after ischemia/reperfusion. Shock. 1997;8:80-85.
44. Jaeschke H, Smith C, Clemens M, et al. Mechisms of inflammatory liver injury: Adhesion molecules and cytotoxicity of neutrophils. Toxicol Appl Pharmacol. 1996;139:213-226.
45. Wanner G, Ertel W, Muller P, et al. Liver ischemia and reperfusion induces a systemic inflammatory response through Kupffer cell activation. Shock. 1996;5:34-40.
46. Colletti L, Burtch G, Remick D, et al. The production of tumor necrosis factor alpha and the development of a pulmonary capillary injury following hepatic ischemia/reperfusion. Transplantation. 1990;49(2):268-272.
47. Jaeschke H. Reactive oxygen and ischemia-reperfsuion injury of the liver. Chem Biol Interact. 1991;79:115-136.
48. Jaeschke H. Kupffer cell-induced oxidant stress during hepatic ischemia-reperfusion: Does the controversy continue? Hepatology. 1999;30:1527-1528.
49. Sawaya D, Brown M, Minardi A, et al. The role of ischemic preconditioning in the recruitment of rolling and adherent leukocytes in hepatic venules after ischemia/reperfusion. J Surg Res. 1999;85:163-170.
50. Yamakawa Y, Takano M, Patel M, et al. Interaction of platelet activating factor, reactive oxygen species generated by xanthine oxidase, and leukocytes in the generation of hepatic injury after shock/resuscitation. Ann Surg. 2000;231:387-398.
51. Vajdova K, Graf R, Clavien P-A. The role of ATP in ischemia reperfusion injury of the liver. Hepatology. 2002;36:1543-1552.
52. Fiegen R, Rauen U, Hartmann M, et al. Decrease of ischemic injury to the isolated perfused rat liver by loop diuretics. Hepatology. 1997;25:1425-1431.
53. Crider B, Xie X, Stone G. Bafilomycin inhibits proton flow through the H+ channel of vacuolar proton pump. J Biol Chem. 1994;269:17379-17381.
54. Carini R, Autelli R, Bellomo G, Albano E. Sodium-mediated swelling is associated with irreversible damage of isolated hepatocytes exposed to hypoxia or mitochondrial toxins. Biochem Biophys Res Commun. 1994;202:360-366.
55. + homeaostasis as a critical step in the development of irreversible hepatocyte injury after adenosine triphosphate depletion. Hepatology. 1995;21:1089-1098.
56. Nishimura T, Nakahara M, Kobayashi S, et al. Ischemic injury in cirrhotic livers: An experimental study of the temporary arrest of hepatic circulation. J Surg Res. 1992;53(3):227-233.
57. Figueras J, Farran L, Benasco C, et al. Vascular occlusion in hepatic resections in cirrhotic rat livers: An experimental study in rats. Liver Transplant Surg. 1997;3(6):617-623.
58. Kishikawa K, Yanaga K, Kakizoe S, et al. Tolerance of the cirrhotic liver to cold ischemia: Ex vivo analysis in rats. Eur Surg Res. 1996;28(2):111-118.
59. Behrns KE, Tsiotos GG, DeSouza NF, et al. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg. 1998;2(3):292-298.
60. Selzner M, Clavien PA. Resection of liver tumors: Special emphasis on neoadjuvant and adjuvant therapy. In: Clavien PA, ed. Malignant Liver Tumors: Current and Emerging Therapies. Malden: Blackwell Science; 1999:137-149.
61. Makuuchi M, Mori T, Gunven P, et al. Safety of hemihepatic vascular occlusion during resection of the liver. Surg Gynecol Obstet. 1987;164(2):155-158.
62. Hardy KJ, Tancheroen S, Shulkes A. Comparison of continuous versus intermittent ischaemia-reperfusion during liver resection in an experimental model. Br J Surg. 1995;82(6):833-836.
63. Horiuchi T, Muraoka R, Tabo T, et al. Optimal cycles of hepatic ischemia and reperfusion for intermittent pedicle clamping during liver surgery. Arch Surg. 1995;130(7):754-758.
64. Isozaki H, Adam R, Gigou M, et al. Experimental study of the protective effect of intermittent hepatic pedicle clamping in the rat. Br J Surg. 1992;79(4):310-313.
65. Belghiti J, Noun R, Zante E, et al. Portal triad clamping or hepatic vascular exclusion for major liver resection. A controlled study. Ann Surg. 1996;224(2):155-161.
66. Cunningham JD, Fong Y, Shriver C, et al. One hundred consecutive hepatic resections. Blood loss, transfusion, and operative technique. Arch Surg. 1994;129(10):1050-1056.
67. Bismuth H, Castaing D, Garden OJ. Major hepatic resection under total vascular exclusion. Ann Surg. 1989;210(1):13-19.
68. Peralta C, Closa D, Xaus C, et al. Hepatic preconditioning in rats is defined by a balance of adenosine and xanthine. Hepatology. 1998;28(3):768-773.
69. Peralta C, Hotter G, Closa D, et al. Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: Role of nitric oxide and adenosine. Hepatology. 1997;25(4):934-937.
70. Peralta C, Hotter G, Closa D, et al. The protective role of adenosine in inducing nitric oxide synthesis in rat liver ischemia preconditioning is mediated by activation of adenosine A2 receptors. Hepatology. 1999;29(1):126-132.
71. Carini R, Grazia de Cesaris M, Splendore R, Albano E. Stimulation of p38 MAP kinase reduces acidosis and Na(+) overload in preconditioned hepatocytes. FEBS Lett. 2001;491(3):180-183.
72. Carini R, De Cesaris M, Splendore R, et al. Singal pathway involved in the development of hypoxic preconditioning in rat hepatocytes. Hepatology. 2001;33(1): 131-139.
73. + accumulation and cell killing in isolated rat hepatocytes exposed to hypoxia. Hepatology. 2000;31:166-172.
74. Pajdo R, Brzozowski T, Konturek P, et al. Ischemic preconditioning, the most effective gastroprotective intervention: Involvement of prostaglandins, nitric oxide, adenosine and sensory nerves. Eur J Pharmacol. 2001;427(3):263-276.
75. Yadav SS, Sindram D, Perry DK, Clavien PA. Ischemic preconditioning protects the mouse liver by inhubition of apoptosis through a caspase-dependent pathway. Hepatology. 1999;30:1223-1231.
76. Caldwell-Kenkel J, Currin R, Tanaka Y, et al. Reperfusion injury to endothelial cells following cold ischemic storage of rat livers. Hepatology. 1989;10:292-299.
77. Holloway C, Harwey P, Strasberg S. Viability of sinusoidal lining cells in cold-preserved rat liver allografts. Transplantation. 1990;49:225-229.
78. Clavien PA. Sinusoidal endothelial cell injury during hepatic preservation and reperfusion. Hepatology. 1998;28(2):281-285.
79. Gao W, Washington MK, Bentley RC, Clavien PA. Antiangiogenic agents protect liver sinusoidal lining cells from cold preservation injury in rat liver transplantation. Gastroenterology. 1997;113(5);1692-1700.
80. Upadhya A, Harvey R, Howard T, et al. Evidence of a role for matrix metalloproteinases in cold preservation injury of the liver in humans and in the rat. Hepatology. 1997;26:922-928.
81. Upadhya G, Strasberg S. Evidence that actin disassembly is a requirement for matrix metalloproteinase secretion by sinusoidal endothelial cells during cold preservation in the rat. Hepatology. 1999;30:169-176.
82. Porte R, Blauw E, Knot E, et al. Role of the donor liver in the origin of platelet disorders and hyperfibrinolysis in liver transplantation. J Hepatol. 1994;21:592-600.
83. Cywes R, Packham M, Tietze L, et al. Role of platelets in hepatic allograft preservation injury in the rat. Hepatology. 1993;18:635-647.
84. Vollmar B, Menger M, Glasz J, et al. Impact of leukocyte-endothelial cell interaction in hepatic schemia-reperfusion injury. Am J Physiol. 1994;267:G787-G793.
85. Vollmar B, Glasz J, Menger M, Messmer K. Leukocytes contribute to hepaic ischemia/reperfusion injury via intercellular adhesion molecule-1 mediated venular adherence. Surgery. 1995;117:195-200.
86. Clavien P-A, Harvey P, Sanabria J, et al. Lymphocyte adherence in the reperfused rat liver allograft. Mechanisms and effects. Hepatology. 1993;17:131-142.
87. Jaeschke H, Smith C. Mechanisms of neutrophil-induced parenchymal cell injury. J Leukocyte Biol. 1997;61:647-653.
88. Jaeschke H, Ho Y, Fischer M, et al. Glutathione peroxidase-deficient mice are more susceptible to neutrophilmediated hepatic parenchymal cell injury during endotoxemia: Importance of an intracellular oxidant stress. Hepatology. 1999;29:443-450.
89. Belzer F, Southard J. Principles of solid organ preservation by cold storage. Transplantation. 1988;45:673.
90. Todo S, Nevy J, Yanaga K, et al. Extended preservation of human liver grafts with UW solution. JAMA. 1989;261:711.
91. Arai M, Thurman R, Lemasters J. Contribution of adenosine A(2) receptors and cyclic adenosine monophosphate to protective ischemic preconditioning of sinusoidal endothelial cells against storage/reperfusion injury in rat livers. Hepatology. 2000;32:297-302.
92. Arai M, Thurman R, Lemasters J. Ischemic preconditioning of rat livers against cold storage-reperfusion injury: Role of nonparenchymal cells and the phenomenon of heterologous preconditioining. Liver Transpl. 2001;7(4): 292-299.
93. Ricciardi R, Schaffer B, Kim R, et al. Protective effects of ischemic preconditioning on the cold-preserved liver are tyrosine kinase dependent. Transplantation. 2001;72(3):406-412.
94. Yin D, Sankary H, Chong A, et al. Protective effect of ischemic preconditioning on liver preservation-reperfusion injury in rats. Transplantation. 1998;66:152-157.
95. Totsuka E, Fung J, Urakami A, et al. Influence of donor cardiopulmonary arrest in human liver transplantation: Possible role of ischemic preconditioning. Hepatology. 2000;31(3):577-580.
96. Fung J. Ischemic preconditioning: Application in clinical liver transplantation. Liver Transpl. 2001;7(4):300-301.
97. Riccardi R, Meyers W, Schaffer B, et al. Protein kinase C inhibiton abrogates hepatic ischemic precondtioning responses. J Surg Res. 2001;97:144-149.